Varicella-Zoster Virus (VZV) Treatment Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Varicella-Zoster Virus (VZV) Treatment in Global, including the following market information:
Global Varicella-Zoster Virus (VZV) Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Varicella-Zoster Virus (VZV) Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acyclovir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Varicella-Zoster Virus (VZV) Treatment include Roche, Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Sanofi, Eli Lilly and Astrazeneca and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Varicella-Zoster Virus (VZV) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Varicella-Zoster Virus (VZV) Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Varicella-Zoster Virus (VZV) Treatment Market Segment Percentages, by Type, 2021 (%)
Global Varicella-Zoster Virus (VZV) Treatment Market Segment Percentages, by Application, 2021 (%)
Global Varicella-Zoster Virus (VZV) Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Varicella-Zoster Virus (VZV) Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Varicella-Zoster Virus (VZV) Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Varicella-Zoster Virus (VZV) Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Varicella-Zoster Virus (VZV) Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acyclovir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Varicella-Zoster Virus (VZV) Treatment include Roche, Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Sanofi, Eli Lilly and Astrazeneca and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Varicella-Zoster Virus (VZV) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Varicella-Zoster Virus (VZV) Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Varicella-Zoster Virus (VZV) Treatment Market Segment Percentages, by Type, 2021 (%)
- Acyclovir
- Valacyclovir
- Famciclovir
- Others
Global Varicella-Zoster Virus (VZV) Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Varicella-Zoster Virus (VZV) Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Varicella-Zoster Virus (VZV) Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Varicella-Zoster Virus (VZV) Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- Merck
- Pfizer
- Novartis
- Abbott
- GlaxoSmithKline
- Sanofi
- Eli Lilly
- Astrazeneca
- Johnson & Johnson
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Varicella-Zoster Virus (VZV) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Varicella-Zoster Virus (VZV) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL VARICELLA-ZOSTER VIRUS (VZV) TREATMENT OVERALL MARKET SIZE
2.1 Global Varicella-Zoster Virus (VZV) Treatment Market Size: 2021 VS 2028
2.2 Global Varicella-Zoster Virus (VZV) Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Varicella-Zoster Virus (VZV) Treatment Players in Global Market
3.2 Top Global Varicella-Zoster Virus (VZV) Treatment Companies Ranked by Revenue
3.3 Global Varicella-Zoster Virus (VZV) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Varicella-Zoster Virus (VZV) Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Varicella-Zoster Virus (VZV) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Varicella-Zoster Virus (VZV) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Varicella-Zoster Virus (VZV) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Varicella-Zoster Virus (VZV) Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Varicella-Zoster Virus (VZV) Treatment Market Size Markets, 2021 & 2028
4.1.2 Acyclovir
4.1.3 Valacyclovir
4.1.4 Famciclovir
4.1.5 Others
4.2 By Type - Global Varicella-Zoster Virus (VZV) Treatment Revenue & Forecasts
4.2.1 By Type - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2022
4.2.2 By Type - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2023-2028
4.2.3 By Type - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Varicella-Zoster Virus (VZV) Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Varicella-Zoster Virus (VZV) Treatment Revenue & Forecasts
5.2.1 By Application - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2022
5.2.2 By Application - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2023-2028
5.2.3 By Application - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Varicella-Zoster Virus (VZV) Treatment Market Size, 2021 & 2028
6.2 By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue & Forecasts
6.2.1 By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2022
6.2.2 By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2023-2028
6.2.3 By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028
6.3.2 US Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.3.3 Canada Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.3.4 Mexico Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028
6.4.2 Germany Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.3 France Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.4 U.K. Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.5 Italy Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.6 Russia Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.8 Benelux Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028
6.5.2 China Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.5.3 Japan Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.5.4 South Korea Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.5.6 India Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028
6.6.2 Brazil Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.6.3 Argentina Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028
6.7.2 Turkey Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.7.3 Israel Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.7.5 UAE Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.1.4 Roche Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.2.4 Merck Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.3.4 Pfizer Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.4.4 Novartis Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 Abbott
7.5.1 Abbott Corporate Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.5.4 Abbott Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.5.5 Abbott Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.6.4 GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.7.4 Sanofi Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.7.5 Sanofi Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.8.4 Eli Lilly Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.8.5 Eli Lilly Key News
7.9 Astrazeneca
7.9.1 Astrazeneca Corporate Summary
7.9.2 Astrazeneca Business Overview
7.9.3 Astrazeneca Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.9.4 Astrazeneca Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.9.5 Astrazeneca Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.10.4 Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.10.5 Johnson & Johnson Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Varicella-Zoster Virus (VZV) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Varicella-Zoster Virus (VZV) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL VARICELLA-ZOSTER VIRUS (VZV) TREATMENT OVERALL MARKET SIZE
2.1 Global Varicella-Zoster Virus (VZV) Treatment Market Size: 2021 VS 2028
2.2 Global Varicella-Zoster Virus (VZV) Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Varicella-Zoster Virus (VZV) Treatment Players in Global Market
3.2 Top Global Varicella-Zoster Virus (VZV) Treatment Companies Ranked by Revenue
3.3 Global Varicella-Zoster Virus (VZV) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Varicella-Zoster Virus (VZV) Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Varicella-Zoster Virus (VZV) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Varicella-Zoster Virus (VZV) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Varicella-Zoster Virus (VZV) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Varicella-Zoster Virus (VZV) Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Varicella-Zoster Virus (VZV) Treatment Market Size Markets, 2021 & 2028
4.1.2 Acyclovir
4.1.3 Valacyclovir
4.1.4 Famciclovir
4.1.5 Others
4.2 By Type - Global Varicella-Zoster Virus (VZV) Treatment Revenue & Forecasts
4.2.1 By Type - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2022
4.2.2 By Type - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2023-2028
4.2.3 By Type - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Varicella-Zoster Virus (VZV) Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Varicella-Zoster Virus (VZV) Treatment Revenue & Forecasts
5.2.1 By Application - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2022
5.2.2 By Application - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2023-2028
5.2.3 By Application - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Varicella-Zoster Virus (VZV) Treatment Market Size, 2021 & 2028
6.2 By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue & Forecasts
6.2.1 By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2022
6.2.2 By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2023-2028
6.2.3 By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028
6.3.2 US Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.3.3 Canada Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.3.4 Mexico Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028
6.4.2 Germany Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.3 France Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.4 U.K. Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.5 Italy Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.6 Russia Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.4.8 Benelux Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028
6.5.2 China Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.5.3 Japan Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.5.4 South Korea Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.5.6 India Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028
6.6.2 Brazil Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.6.3 Argentina Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028
6.7.2 Turkey Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.7.3 Israel Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
6.7.5 UAE Varicella-Zoster Virus (VZV) Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.1.4 Roche Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.2.4 Merck Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.3.4 Pfizer Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.4.4 Novartis Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 Abbott
7.5.1 Abbott Corporate Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.5.4 Abbott Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.5.5 Abbott Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.6.4 GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.7.4 Sanofi Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.7.5 Sanofi Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.8.4 Eli Lilly Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.8.5 Eli Lilly Key News
7.9 Astrazeneca
7.9.1 Astrazeneca Corporate Summary
7.9.2 Astrazeneca Business Overview
7.9.3 Astrazeneca Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.9.4 Astrazeneca Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.9.5 Astrazeneca Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Major Product Offerings
7.10.4 Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Revenue in Global Market (2017-2022)
7.10.5 Johnson & Johnson Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Varicella-Zoster Virus (VZV) Treatment Market Opportunities & Trends in Global Market
Table 2. Varicella-Zoster Virus (VZV) Treatment Market Drivers in Global Market
Table 3. Varicella-Zoster Virus (VZV) Treatment Market Restraints in Global Market
Table 4. Key Players of Varicella-Zoster Virus (VZV) Treatment in Global Market
Table 5. Top Varicella-Zoster Virus (VZV) Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Varicella-Zoster Virus (VZV) Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Varicella-Zoster Virus (VZV) Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Varicella-Zoster Virus (VZV) Treatment Product Type
Table 9. List of Global Tier 1 Varicella-Zoster Virus (VZV) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Varicella-Zoster Virus (VZV) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Varicella-Zoster Virus (VZV) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Varicella-Zoster Virus (VZV) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Varicella-Zoster Virus (VZV) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Varicella-Zoster Virus (VZV) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 32. Roche Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 35. Merck Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 38. Pfizer Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 41. Novartis Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Corporate Summary
Table 43. Abbott Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 44. Abbott Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 47. GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 50. Sanofi Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly Corporate Summary
Table 52. Eli Lilly Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 53. Eli Lilly Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Astrazeneca Corporate Summary
Table 55. Astrazeneca Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 56. Astrazeneca Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 59. Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 1. Varicella-Zoster Virus (VZV) Treatment Market Opportunities & Trends in Global Market
Table 2. Varicella-Zoster Virus (VZV) Treatment Market Drivers in Global Market
Table 3. Varicella-Zoster Virus (VZV) Treatment Market Restraints in Global Market
Table 4. Key Players of Varicella-Zoster Virus (VZV) Treatment in Global Market
Table 5. Top Varicella-Zoster Virus (VZV) Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Varicella-Zoster Virus (VZV) Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Varicella-Zoster Virus (VZV) Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Varicella-Zoster Virus (VZV) Treatment Product Type
Table 9. List of Global Tier 1 Varicella-Zoster Virus (VZV) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Varicella-Zoster Virus (VZV) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Varicella-Zoster Virus (VZV) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Varicella-Zoster Virus (VZV) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Varicella-Zoster Virus (VZV) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Varicella-Zoster Virus (VZV) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 32. Roche Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 35. Merck Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 38. Pfizer Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 41. Novartis Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Corporate Summary
Table 43. Abbott Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 44. Abbott Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 47. GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 50. Sanofi Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly Corporate Summary
Table 52. Eli Lilly Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 53. Eli Lilly Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Astrazeneca Corporate Summary
Table 55. Astrazeneca Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 56. Astrazeneca Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Product Offerings
Table 59. Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Varicella-Zoster Virus (VZV) Treatment Segment by Type in 2021
Figure 2. Varicella-Zoster Virus (VZV) Treatment Segment by Application in 2021
Figure 3. Global Varicella-Zoster Virus (VZV) Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Varicella-Zoster Virus (VZV) Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Varicella-Zoster Virus (VZV) Treatment Revenue in 2021
Figure 8. By Type - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 12. US Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 24. China Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Astrazeneca Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Varicella-Zoster Virus (VZV) Treatment Segment by Type in 2021
Figure 2. Varicella-Zoster Virus (VZV) Treatment Segment by Application in 2021
Figure 3. Global Varicella-Zoster Virus (VZV) Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Varicella-Zoster Virus (VZV) Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Varicella-Zoster Virus (VZV) Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Varicella-Zoster Virus (VZV) Treatment Revenue in 2021
Figure 8. By Type - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 12. US Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 24. China Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Varicella-Zoster Virus (VZV) Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Astrazeneca Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
